Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,603 INR | +0.21% | +0.02% | -6.23% |
Apr. 08 | Galaxy Surfactants Forms New Wholly-Owned Subsidiary | MT |
Apr. 05 | Galaxy Surfactants Limited Announces Incorporation of Wholly Owned Subsidiary Company | CI |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 30.58 and 25.52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.23% | 1.11B | C+ | ||
+11.47% | 63.22B | A- | ||
-3.47% | 46.34B | A- | ||
+13.72% | 39.97B | B+ | ||
+17.83% | 25.46B | A- | ||
+7.27% | 18.68B | C+ | ||
-0.57% | 17.24B | B+ | ||
-21.73% | 15.81B | A- | ||
+0.22% | 14.9B | B+ | ||
-19.10% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GALAXYSURF Stock
- Ratings Galaxy Surfactants Limited